AI-Powered Biotech Can Help Deploy a Vaccine In Record Time Simulators that can rapidly test trillions of options would accelerate the slow and costly process of human clinical trials.
The sprint to solve coronavirus protein structures — and disarm them with drugs Stopping the pandemic could rely on breakneck efforts to visualize SARS-CoV-2 proteins and use them to design drugs and vaccines.
How we’ll get back to the lab during COVID-19 Careful planning and lots of distancing are critical for R&D labs that have stayed open and those looking to restart